Alveron Pharma

Nijmegen, The Netherlands

Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.

$5.3M raised

Dec 2024

Seed

Biopharma Biotechnology Emergency Medicine Pharmaceutical

Top Investors

Thuja CapitalBroadview VenturesOostNLNetherlands Enterprise AgencySanquin

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alveron Pharma

How much funding has Alveron Pharma raised?

Alveron Pharma has raised $5.3M in total funding. The most recent round was Seed. The last funding was announced in December 2024.

Who are Alveron Pharma's investors?

Alveron Pharma's investors include Thuja Capital, Broadview Ventures, OostNL, Netherlands Enterprise Agency, Sanquin.

Where is Alveron Pharma headquartered?

Alveron Pharma is headquartered in Nijmegen, The Netherlands.

What does Alveron Pharma do?

Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.

What stage is Alveron Pharma at?

Alveron Pharma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 6, 2024.

MLA

"Alveron Pharma — Funding & Investors." VCBacked, December 6, 2024, https://www.vcbacked.co/company/alveron-pharma. Accessed June 17, 2026.

APA

VCBacked. (2024). Alveron Pharma — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/alveron-pharma

Wikipedia (cite web)

{{cite web |title=Alveron Pharma — Funding & Investors |url=https://www.vcbacked.co/company/alveron-pharma |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 6, 2024.

Similar Companies in Biopharma